These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10422886)

  • 41. Physiological and pharmacological characterization of the spinal tachykinin NK2 receptor.
    Lepre M; Olpe HR; Evans RH; Brugger F
    Eur J Pharmacol; 1994 Jun; 258(1-2):23-31. PubMed ID: 7523150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
    Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
    Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK
    Zhong W; Chebolu S; Darmani NA
    Neurochem Int; 2019 Jan; 122():106-119. PubMed ID: 30453005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.
    Chizh BA; Cumberbatch MJ; Birch PJ; Headley PM
    Br J Pharmacol; 1995 Jul; 115(6):1013-9. PubMed ID: 7582497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
    Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
    Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
    Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
    Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of the rat mesolimbic dopamine pathway by neurokinins.
    Elliott PJ; Mason GS; Graham EA; Turpin MP; Hagan RM
    Behav Brain Res; 1992 Oct; 51(1):77-82. PubMed ID: 1282818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinal nociceptin inhibits septide but not N-methyl-D-aspartate-induced nociceptive behavior in rats.
    Villanueva N; Lastra A; Hidalgo A; Baamonde A; Menéndez L
    Eur J Pharmacol; 2002 Jun; 445(1-2):83-6. PubMed ID: 12065197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
    Hall JM; Morton IK
    Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs.
    Rupniak NM; Jackson A
    Eur J Pharmacol; 1994 Sep; 262(1-2):171-5. PubMed ID: 7529183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
    Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
    Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose intrathecal clonidine releases tachykinins in rat spinal cord.
    Luo L; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 1993 Apr; 235(1):157-9. PubMed ID: 7686104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar behavioural effects of 5-hydroxytryptamine and substance P injected intrathecally in mice.
    Fasmer OB; Berge OG; Hole K
    Neuropharmacology; 1983 Apr; 22(4):485-7. PubMed ID: 6190102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptors.
    Bertrand C; Nadel JA; Graf PD; Geppetti P
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):909-14. PubMed ID: 7692775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
    Maubach KA; Jones RS
    Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of the neurokinin-1 receptor in rat spinal astrocytes induces Ca2+ release from IP3-sensitive Ca2+ stores and extracellular Ca2+ influx through TRPC3.
    Miyano K; Morioka N; Sugimoto T; Shiraishi S; Uezono Y; Nakata Y
    Neurochem Int; 2010 Dec; 57(8):923-34. PubMed ID: 20933035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of substance P analogs on neurokinin 1 receptor agonists in the mouse spinal cord.
    Sakurada T; Yamada T; Tan-no K; Manome Y; Sakurada S; Kisara K; Ohba M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):205-10. PubMed ID: 1717679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the non-peptide blocker (+/-) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts.
    Ziche M; Parenti A; Amerini S; Zawieja D; Maggi CA; Ledda F
    Neuropeptides; 1996 Aug; 30(4):345-54. PubMed ID: 8914860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.